BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38632341)

  • 1. Tumor promoting effect of spheroids in an orthotopic prostate cancer mouse model.
    Bastian JLD; Zeuschner P; Stöckle M; Junker K; Linxweiler J
    Sci Rep; 2024 Apr; 14(1):8835. PubMed ID: 38632341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mouse model of human prostate cancer to study intraprostatic tumor growth and the development of lymph node metastases.
    Linxweiler J; Körbel C; Müller A; Hammer M; Veith C; Bohle RM; Stöckle M; Junker K; Menger MD; Saar M
    Prostate; 2018 Jun; 78(9):664-675. PubMed ID: 29572953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice.
    Sato N; Gleave ME; Bruchovsky N; Rennie PS; Beraldi E; Sullivan LD
    Cancer Res; 1997 Apr; 57(8):1584-9. PubMed ID: 9108464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated fibroblasts stimulate primary tumor growth and metastatic spread in an orthotopic prostate cancer xenograft model.
    Linxweiler J; Hajili T; Körbel C; Berchem C; Zeuschner P; Müller A; Stöckle M; Menger MD; Junker K; Saar M
    Sci Rep; 2020 Jul; 10(1):12575. PubMed ID: 32724081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-derived, three-dimensional spheroid cultures provide a versatile translational model for the study of organ-confined prostate cancer.
    Linxweiler J; Hammer M; Muhs S; Kohn M; Pryalukhin A; Veith C; Bohle RM; Stöckle M; Junker K; Saar M
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):551-559. PubMed ID: 30474758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines.
    Wu TT; Sikes RA; Cui Q; Thalmann GN; Kao C; Murphy CF; Yang H; Zhau HE; Balian G; Chung LW
    Int J Cancer; 1998 Sep; 77(6):887-94. PubMed ID: 9714059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
    Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic model for human prostate cancer using orthotopic implantation in nude mice.
    Stephenson RA; Dinney CP; Gohji K; Ordóñez NG; Killion JJ; Fidler IJ
    J Natl Cancer Inst; 1992 Jun; 84(12):951-7. PubMed ID: 1378502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-malignancy orthotopic nude mouse model of human prostate cancer LNCaP.
    Wang X; An Z; Geller J; Hoffman RM
    Prostate; 1999 May; 39(3):182-6. PubMed ID: 10334107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
    Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ
    Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical orthotopic implantation allows high lung and lymph node metastatic expression of human prostate carcinoma cell line PC-3 in nude mice.
    An Z; Wang X; Geller J; Moossa AR; Hoffman RM
    Prostate; 1998 Feb; 34(3):169-74. PubMed ID: 9492844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasis.
    Li W; Wang BE; Moran P; Lipari T; Ganesan R; Corpuz R; Ludlam MJ; Gogineni A; Koeppen H; Bunting S; Gao WQ; Kirchhofer D
    Cancer Res; 2009 Nov; 69(21):8395-402. PubMed ID: 19843851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A metastatic human prostate cancer model using intraprostatic implantation of tumor produced by PC-3 neolacZ transfected cells.
    Tsingotjidou AS; Ahluwalia R; Zhang X; Conrad H; Emmanouilides C
    Int J Oncol; 2003 Dec; 23(6):1569-74. PubMed ID: 14612928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: efficacy of flt3 ligand immunotherapy.
    Somers KD; Brown RR; Holterman DA; Yousefieh N; Glass WF; Wright GL; Schellhammer PF; Qian J; Ciavarra RP
    Int J Cancer; 2003 Dec; 107(5):773-80. PubMed ID: 14566827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice.
    Zhao Z; He J; Kang R; Zhao S; Liu L; Li F
    Prostate; 2016 Feb; 76(2):184-98. PubMed ID: 26477693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-Associated Fibroblasts Modify the Response of Prostate Cancer Cells to Androgen and Anti-Androgens in Three-Dimensional Spheroid Culture.
    Eder T; Weber A; Neuwirt H; Grünbacher G; Ploner C; Klocker H; Sampson N; Eder IE
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line.
    Wang Y; Xue H; Cutz JC; Bayani J; Mawji NR; Chen WG; Goetz LJ; Hayward SW; Sadar MD; Gilks CB; Gout PW; Squire JA; Cunha GR; Wang YZ
    Lab Invest; 2005 Nov; 85(11):1392-404. PubMed ID: 16155594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional cellular spheroid formation provides human prostate tumor cells with tissue-like features.
    Takagi A; Watanabe M; Ishii Y; Morita J; Hirokawa Y; Matsuzaki T; Shiraishi T
    Anticancer Res; 2007; 27(1A):45-53. PubMed ID: 17352215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid detection of candidate metastatic foci in the orthotopic inoculation model of androgen-sensitive prostate cancer cells introduced with green fluorescent protein.
    Maeda H; Segawa T; Kamoto T; Yoshida H; Kakizuka A; Ogawa O; Kakehi Y
    Prostate; 2000 Dec; 45(4):335-40. PubMed ID: 11102959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.